BOCA RATON, Fla., Oct. 30, 2013 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, has opened its 14th U.S. plasma collection center. The state-of-the-art, 16,000 square foot facility is located at 3110 lake Washington Road in Melbourne, Florida and officially opened its doors on October 24, 2013.
"We are pleased with the continued growth of our U.S. plasma collection network," said Jordan Siegel, BPC's Chief Executive Officer. "This is the second new center we have opened this year and we are continuing to expand our U.S. operations to address the global demand for this very important source material."
The plasma collected at BPC's centers is used to manufacture life-saving therapies including Biotest Pharmaceuticals' BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] for the treatment of primary humoral immunodeficiency (PI) and Nabi-HB hyperimmune globulin for the treatment of acute exposure to blood containing hepatitis B surface antigen (HBsAg), perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection.
BPC expects to add more than 40 jobs to Melbourne's local economy and currently has career opportunities available for Licensed Practical Nurses/Registered Nurses, phlebotomists and various other positions. In addition to supporting the local economy through employment opportunities, the center is actively recruiting plasma donors.
About Biotest Pharmaceuticals Corporation
Biotest Pharmaceuticals Corporation develops and manufactures pharmaceutical and biotherapeutic products with a specialization in immunology. Biotest Pharmaceuticals was formed in 2007 as part of the Biotest AG acquisition of Nabi Pharmaceuticals' Biologics business unit, including its plasmapheresis centers across the United States. The company employs over 700 people in the U.S. Biotest Pharmaceuticals is a subsidiary of Biotest AG, a German-based global provider of plasma proteins that employs approximately 2,000 people worldwide. To learn more about Biotest Pharmaceuticals and how we help make a difference in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com.
SOURCE Biotest Pharmaceuticals Corporation